Consequences of warfarin suspension after major bleeding in a cohort of very elderly atrial fibrillation patients

被引：0
|
作者：
Zoppellaro, G. [1 ]
Bertozzo, G. [2 ]
Jose, S. Padayattil [1 ]
Granziera, S. [3 ]
Denas, G. [1 ]
Marigo, L. [2 ]
Rossi, K. [2 ]
Bracco, A. [1 ]
Ninnivaggi, C. [2 ]
Petruzzellis, F. [2 ]
Nante, G. [2 ]
Pengo, V. [1 ]
机构：
[1] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Padua, Italy
[2] Univ Hosp Padova, Geriatr Clin, Padua, Italy
[3] Osped Classificato Villa Salus, Venice, Italy
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2603
引用
收藏
页码：511 / 512
页数：2
相关论文
共 50 条
  • [21] Major bleeding events in elderly patients with atrial fibrillation and vitamin k antagonists
    Gallego Munoz, C.
    Bulo Concellon, R.
    Dominguez Cantero, M.
    Blanco Sanchez, G.
    Salguero Olid, A.
    Romero Hernandez, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 538 - 538
  • [22] Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study
    Wang, Shirley V.
    Franklin, Jessica M.
    Glynn, Robert J.
    Schneeweiss, Sebastian
    Eddings, Wesley
    Gagne, Joshua J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [23] Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation
    Boulanger, Luke
    Hauch, Ole
    Friedman, Mark
    Foster, Talia
    Dixon, Deirdre
    Wygant, Gail
    Menzin, Joseph
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1024 - 1029
  • [24] Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation
    Levi, Marcel
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (06)
  • [25] Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a population-based study
    Azoulay, L.
    Dell'aniello, S.
    Simon, T.
    Renoux, C.
    Suissa, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 671 - 672
  • [26] Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a population-based study
    Azoulay, L.
    Dell'aniello, S.
    Simon, T.
    Renoux, C.
    Suissa, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 671 - 672
  • [27] Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
    Chao, Tze-Fan
    Liu, Chia-Jen
    Lin, Yenn-Jiang
    Chang, Shih-Lin
    Lo, Li-Wei
    Hu, Yu-Feng
    Tuan, Ta-Chuan
    Liao, Jo-Nan
    Chung, Fa-Po
    Chen, Tzeng-Ji
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    CIRCULATION, 2018, 138 (01) : 37 - 47
  • [28] Rivaroxaban in very elderly patients with atrial fibrillation
    Lamaida, Norman
    Cristiano, Giuseppina
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G33 - G33
  • [29] Rivaroxaban in very elderly patients with atrial fibrillation
    Lamaida, Norman
    Cristiano, Giuseppina
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [30] STROKE AND BLEEDING IN OLDER PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia
    Essebag, Vidal
    Eisenberg, Mark
    Rahme, Elham
    Humphries, Karin
    Tu, Jack
    Pilote, Louise
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E372 - E372
12345